Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 63   

Articles published

AZN 4,720.50 0.00 (0.00%)
price chart
Three Conservative Stocks To Play The Stock Market Rally
A quick perusal of AstraZeneca's financials and chart pattern suggests that if the company can boost its top line growth metrics in the future, the stock price could really take off as it has been basing and consolidating for 15 years!
Related articles »  
AstraZeneca Plans to Cut 7300 Jobs
U.K. drug maker AstraZeneca PLC said Thursday it would eliminate another 7,300 jobs, bringing its total cuts over the past five years to nearly 30,000.
AstraZeneca to Buy Back $4.5 Billion in Stock, Cut Jobs as Patents Expire  Bloomberg
AstraZeneca closing Montreal R&D plant  Globe and Mail
Related articles »  
Making the right exit: Lessons learned from AstraZeneca and IBM
The MSA also contained an obligation on AstraZeneca to produce an IT transfer plan for IBM detailing how the services would be transferred away from IBM.
Related articles »  
Europe approves AstraZeneca thyroid cancer drug
Vandetanib was once seen as a potential $1 billion (630 million pound) plus blockbuster for AstraZeneca but suffered a major setback after failing to extend survival in patients with lung cancer.
Related articles »  
AstraZeneca Loses Ruling Over 2018 and 2021 Crestor Patents
Feb. 9 (Bloomberg) -- AstraZeneca Plc lost a U.S. appeals court bid to protect its best-selling drug, Crestor, from generic competition until as late as 2021.
Related articles »  
Europe Job Losses Accelerate With AstraZeneca-to-PepsiCo Firing Employees
Global companies from NEC Corp. (6701) to PepsiCo Inc. (PEP) and AstraZeneca Plc (AZN) are chopping jobs more than three times faster than in 2011 as they brace for recession in Europe and a slowdown in China.
Related articles »  
Pfizer, AstraZeneca face revenue drop as patent protection expires
Pfizer Canada Inc. lost its bid to block the production of a generic eye drug by Apotex Inc. when the Supreme Court of Canada declined Thursday to hear the company's appeal.
Related articles »  
Astra takes brand cancer drug straight to patients
(Reuters) - AstraZeneca Plc is selling breast cancer drug Arimidex directly to U.S. patients, offering an option for people who want to pay for the brand instead of generic versions.
Related articles »  
R&D in Quebec pharma industry continues to erode
PetroChina in shale deal China is moving ever deeper into Canada's energy industry with a deal by PetroChina Co. today to join Royal Dutch Shell PLC in a shale gas project in northeastern British Columbia. The company did not disclose the pricetag for ...
Related articles »  
Big lenders urged to keep supporting CPP
Some of the UK's biggest banks are under political pressure not to cut financial ties with CPP as the troubled credit card and identity theft insurer faces the threat of administration following a mis-selling scandal.
Related articles »